UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of CYP3A53 genotype on exposure and efficacy of quetiapine: A retrospective, cohort study

Journal of affective disorders, 2025-02, Vol.370, p.134-139

2025

Volltextzugriff (PDF)

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

The New England journal of medicine, 2023-10, Vol.389 (14), p.1298-1309

2023

Volltextzugriff (PDF)

Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration

European journal of pharmaceutical sciences, 2016-08, Vol.91, p.196-207

2016

Volltextzugriff (PDF)

Optimization and evaluation of modified release solid dosage forms using artificial neural network

Scientific reports, 2024-07, Vol.14 (1), p.16358-8, Article 16358

2024

Volltextzugriff (PDF)

Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder

Clinical therapeutics, 2020-08, Vol.42 (8), p.1483-1493.e1

2020

Volltextzugriff (PDF)

The stability of quetiapine oral suspension compounded from commercially available tablets

PloS one, 2021-08, Vol.16 (8), p.e0255963-e0255963

2021

Volltextzugriff (PDF)

Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression

European neuropsychopharmacology, 2024-08, Vol.85, p.58-65

2024

Volltextzugriff (PDF)

Determination of quetiapine in human plasma by LC–MS/MS and its application in a bioequivalence study

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2017-08, Vol.1060, p.10-14

2017

Volltextzugriff (PDF)

Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets

European journal of clinical pharmacology, 2024-06, Vol.80 (6), p.839-845

2024

Volltextzugriff (PDF)

The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies

Neuroscience and biobehavioral reviews, 2018-03, Vol.86, p.36-50

2018

Volltextzugriff (PDF)

Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression

Clinical therapeutics, 2020-06, Vol.42 (6), p.1067-1076.e2

2020

Volltextzugriff (PDF)

Dose–response association of acute‐phase quetiapine treatment with risk of new‐onset hypothyroidism in schizophrenia patients

British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4823-4830

2021

Volltextzugriff (PDF)

Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression

Psychopharmacology, 2018-10, Vol.235 (10), p.2859-2869

2018

Volltextzugriff (PDF)

Lower-dose quetiapine safe and effective for personality disorder

Psychopharmacology update, 2014-11, Vol.25 (11), p.7

2014

Volltextzugriff (PDF)

Association of new-onset diabetes mellitus in adults with schizophrenia treated with clozapine versus patients treated with olanzapine, risperidone, or quetiapine: A systematic review and meta-analysis

Schizophrenia research, 2024-09, Vol.271, p.371-379

2024

Volltextzugriff (PDF)

Semi-Mechanistic Pharmacokinetic Modeling of Lipid Core Nanocapsules: Understanding Quetiapine Plasma and Brain Disposition in a Neurodevelopmental Animal Model of Schizophrenia

The Journal of pharmacology and experimental therapeutics, 2020-10, Vol.375 (1), p.49-58

2020

Volltextzugriff (PDF)

Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis

Psychopharmacology, 2018, Vol.235 (1), p.245-255

2018

Volltextzugriff (PDF)

Risk of ischemic stroke associated with the use of antipsychotic drugs in elderly patients: a retrospective cohort study in Korea

PloS one, 2015-03, Vol.10 (3), p.e0119931-e0119931

2015

Volltextzugriff (PDF)

Effect of Paroxetine or Quetiapine Combined With Oxycodone vs Oxycodone Alone on Ventilation During Hypercapnia: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-10, Vol.328 (14), p.1405

2022

Volltextzugriff (PDF)

Quantification of neurotransmitters in microdialysate samples following quetiapine dosing to schizophrenia phenotyped rats using a validated LC-MS/MS method

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020-10, Vol.1155, p.122282, Article 122282

2020

Volltextzugriff (PDF)

Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate

Current drug delivery, 2018-01, Vol.15 (6), p.818-828

2018

Volltextzugriff (PDF)

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis

Journal of clinical psychopharmacology, 2021-11, Vol.41 (6), p.667-672

2021

Volltextzugriff (PDF)

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events

Journal of clinical epidemiology, 2019-09, Vol.113, p.11-19

2019

Volltextzugriff (PDF)

Synthesis Folate-linked Chitosan-coated Quetiapine/BSA Nano-Carriers as the Efficient Targeted Anti-Cancer Drug Delivery System

Molecular biotechnology, 2024-09, Vol.66 (9), p.2297-2307

2024

Volltextzugriff (PDF)

1 – 25 von 4.660

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.116)
Mit Volltextzugriff
(3.433)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.474)
Life Sciences & Biomedicine
(3.381)
Humans
(3.079)
Quetiapine
(2.606)
Quetiapine Fumarate
(2.358)
Psychiatry
(2.070)
Male
(1.843)
Antipsychotic Agents - Therapeutic Use
(1.797)
Female
(1.682)
Dibenzothiazepines - Therapeutic Use
(1.462)
Adult
(1.422)
Pharmacology & Pharmacy
(1.317)
Antipsychotic Agents - Adverse Effects
(1.305)
Middle Aged
(1.011)
Dibenzothiazepines - Adverse Effects
(967)
Neurosciences & Neurology
(925)
Biological And Medical Sciences
(904)
Schizophrenia
(900)
Medical Sciences
(896)
Antipsychotics
(856)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(19)
... seit 30 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Effect of CYP3A53 genotype on exposure and efficacy of quetiapine: A retrospective, cohort study

Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression

Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration

Optimization and evaluation of modified release solid dosage forms using artificial neural network

Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder

The stability of quetiapine oral suspension compounded from commercially available tablets

Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression

Determination of quetiapine in human plasma by LC–MS/MS and its application in a bioequivalence study

Dose-dependent effect of lamotrigine on quetiapine serum concentration in patients using instant release tablets

The use of quetiapine in the treatment of major depressive disorder: Evidence from clinical and experimental studies

Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

Dose–response association of acute‐phase quetiapine treatment with risk of new‐onset hypothyroidism in schizophrenia patients

Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression

Lower-dose quetiapine safe and effective for personality disorder

Association of new-onset diabetes mellitus in adults with schizophrenia treated with clozapine versus patients treated with olanzapine, risperidone, or quetiapine: A systematic review and meta-analysis

Semi-Mechanistic Pharmacokinetic Modeling of Lipid Core Nanocapsules: Understanding Quetiapine Plasma and Brain Disposition in a Neurodevelopmental Animal Model of Schizophrenia

Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis

Risk of ischemic stroke associated with the use of antipsychotic drugs in elderly patients: a retrospective cohort study in Korea

Effect of Paroxetine or Quetiapine Combined With Oxycodone vs Oxycodone Alone on Ventilation During Hypercapnia: A Randomized Clinical Trial

Quantification of neurotransmitters in microdialysate samples following quetiapine dosing to schizophrenia phenotyped rats using a validated LC-MS/MS method

Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12-17 Years, With First Episode Psychosis

Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events

Synthesis Folate-linked Chitosan-coated Quetiapine/BSA Nano-Carriers as the Efficient Targeted Anti-Cancer Drug Delivery System

Suchergebnisse filtern